Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cardiac AI Monitoring And Diagnostics Market Grown from 2024 to 2025?

The size of the cardiac ai monitoring and diagnostics market has seen a dramatic increase in recent years. Its growth is projected to jump from $1.71 billion in 2024 to $2.16 billion in 2025, representing a compound annual growth rate (CAGR) of 26.4%. This significant growth during the historic period is linked to various factors including aging population trends, the surge in remote patient monitoring, hike in healthcare spending, clinical research and validation studies, and an emphasis on proactive healthcare.

What Growth Rate Is Anticipated for the Cardiac AI Monitoring And Diagnostics Market in the Coming Years?

The market size for cardiac ai monitoring and diagnostics is predicted to witness a significant surge in the upcoming years, reaching a projected value of $5.54 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 26.6%. Factors contributing to this anticipated growth during the forecast period include the proliferation of wearable and IoT devices, a rise in telemedicine and remote monitoring adoption, the involvement of big data analytics and predictive modeling, a shift towards patient-centric care, and remote patient engagement, along with the advances in healthcare infrastructure. Key trends expected in this timeframe are the fusion of AI with wearable technology, individualized risk evaluation and treatment strategy, the use of predictive analytics for heart-related events, the consolidation of various data channels, and the establishment of standards for interoperability and data integration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13820&type=smp

Who Are the Leading Companies in the Cardiac AI Monitoring And Diagnostics Market?

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

What Are the Key Drivers of the Cardiac AI Monitoring And Diagnostics Market?

The cardiac AI monitoring and diagnostics industry is likely to see significant growth due to the increasing instances of cardiovascular diseases. These diseases, including cerebrovascular, coronary heart, rheumatic heart disease, and others, affect the heart and blood vessels. Early detection, risk evaluation, and customised treatment of these conditions is made possible by cardiac AI monitoring and diagnostics, improving patient results significantly. For example, data from British Heart Foundation, a cardiovascular research charity based in the UK, from September 2024 states that roughly 7.6 million people in the UK suffer from heart and circulatory diseases. These afflictions are more widely spread among men (four million) and women (3.6 million). They are also the reason behind 27% of all deaths in the UK, leading to over 170,000 deaths a year or around 480 deaths per day — one death every three minutes. Therefore, the rising rate of cardiovascular diseases is fuelling the growth of the cardiac AI monitoring and diagnostics industry.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13820&type=smp

What Are the Key Market Segments in the Cardiac AI Monitoring And Diagnostics Industry?

The cardiac ai monitoring and diagnostics market covered in this report is segmented –

1) By Type: Cardiac Diagnostics, Cardiac Monitoring

2) By Product: Software, Hardware

3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD), Cardiac Arrhythmias, Ischemic Stroke, Other Applications

4) By End Users: Hospitals, Diagnostic Centers, Other End Users

Subsegments:

1) By Cardiac Diagnostics: ECG Analysis, Echocardiography Analysis, Cardiac Imaging, Biomarker Analysis

2) By Cardiac Monitoring: Wearable Cardiac Monitors, Remote Patient Monitoring Systems, Implantable Cardiac Devices, Continuous ECG Monitoring Systems

What Are the Latest Trends in the Cardiac AI Monitoring And Diagnostics Market?

In an effort to solidify their standing in the market, key firms in the cardiac AI monitoring and diagnostics sector are focusing on the development of medical equipment based on cutting-edge technology, such as AI-powered implantable cardiac monitors. These devices continually keep an eye on heart functionality. As an illustration, Biotronik, a German company specializing in cardiovascular biomedical research and technology, received approval from the US Food and Drug Administration (FDA) in May 2023 for their BIOMONITOR IV implantable cardiac monitor (ICM). This ICM employs BIOTRONIK’s state-of-the-art, AI-driven SmartECG algorithm, which cuts down false recognitions by 86% while conserving 98% of genuine occurrences, courtesy of its advanced algorithms. This breakthrough technology enhances detection precision for medical professionals, reducing erroneous positive alerts and aiding them in swiftly and accurately diagnosing specific heart issues. Additionally, BIOMONITOR IV is the first ICM to differentiate between premature ventricular contractions (PVCs) and premature atrial contractions (PACs).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-ai-monitoring-and-diagnostics-global-market-report

What Are the Key Regional Markets in the Cardiac AI Monitoring And Diagnostics Industry?

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13820

This Report Delivers Insight On:

1. How big is the cardiac ai monitoring and diagnostics market, and how is it changing globally?

2. Who are the major companies in the cardiac ai monitoring and diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the cardiac ai monitoring and diagnostics market right now?

4. Which products or customer segments are growing the most in the cardiac ai monitoring and diagnostics market?

5. What factors are helping or slowing down the growth of the cardiac ai monitoring and diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model